Advertisement

Topics

Latest Dermatology NewsRSS

08:11 EDT 24th June 2017 | BioPortfolio

Paratek Pharmaceuticals Announces FDA Grant of Qualified Infectious Disease Product (QIDP) Designation for Its Lead Product Candidate, Omadacycline

BOSTON, Jan. 3, 2013 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead antibiotic candidate, omadacycline (formerly known as PTK 0796), as a Qualified Infectious Disease Product (QIDP) for both intravenous (IV) and oral formulations in the treatment of acute bacterial skin and skin structure infections (...

Leading Dermatologist Michael P. Heffernan, M.D. and Renowned Rheumatologist Alisa E. Koch, M.D. Join Lilly Autoimmune Team

INDIANAPOLIS, Jan. 3, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced that Michael P. Heffernan, M.D., a nationally recognized expert in complex medical dermatology, psoriasis and clinical trials, has joined its autoimmune team as distinguished medical fellow. Alisa E. Koch, M.D., a rheumatologist who has won numerous academic awards for her extensive work in rheumatoid ...

MELA Sciences Names Rpr Marketing Communications as its New Agency of Record

NEW YORK, Jan. 3, 2013 /PRNewswire/ -- MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that developed MelaFind®, a breakthrough device intended to help dermatologists detect melanoma when it is still curable, announced today that it has named Rpr Marketing Communications as its U.S. public relations agency of record. (Logo: http://photos.prnewswire.com/prnh/20130103/NY360...

Renew your Skin in the New Year at Renaissance Laser & Vein Institute with Laser Vein and Hair Removal Treatments

LOS ANGELES, Dec. 31, 2012 /PRNewswire/ -- As 2013 approaches, many women and men are thinking along the lines of self-improvement. While New Year's resolutions are geared toward curtailing bad habits or instituting good ones, a person might be thinking in terms of improving their personal appearance. Many people strive to lose the extra holiday weight by the end of January, while some are determi...

Psoriasis, psoriatic arthritis patients showed similar rates of metabolic syndrome

MADRID — Patients with psoriatic arthritis and psoriasis had a similar prevalence of metabolic syndrome and hepatic stiffness, according to findings presented at the EULAR Annual Congress, here. “What we know from the literature is that metabolic syndrome is more prevalent in psoriatic arthritis and psoriasis patients with respect to the general population,” presenter Augusta Ortolan, MD, sa...

Global and Chinese Skin Surface Microscope Industry, 2017 Market Research Report [Updated: 21062017] Prices from USD $3000

The 'Global and Chinese Skin Surface Microscope Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Skin Surface Microscope industry with a focus on the Chinese market. The report provides key statistics on the market status of the Skin Surface Microscope manufacturers and is a valuable source of guidance and direction for companies and...

EMA recommends approval of Humira biosimilar Imraldi

The European Medicines Agency has recommended the approval of the Imraldi, making it the third anti-TNF biosimilar candidate to receive a positive opinion from the Committee for Medicinal Products for Human Use, the manufacturer announced.Imraldi (SB5, Samsung Bioepis) is a biosimilar candidate referencing Humira (adalimumab, AbbVie), indicated for rheumatoid arthritis, juvenile idiopathic arthrit...

Samsung Bioepis' Imraldi® (Adalimumab) Recommended for Approval by European Medicines Agency

The positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use will now be referred to the European Commission which will review and decide on the grant of a marketing authorization for Imraldi® Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Commi...

ARTHRITE PSORIASIQUE : 2 thérapeutiques contre les symptômes articulaires et dermatologiques - EULAR 2017

Près d'un patient sur 5 qui suit un traitement systémique pour le psoriasis (comprimés, injections ou infusions) a des symptômes sévères persistants, malgré son traitement. Ces données de 2 études, présentées à l'European Congress of Rheumatology (EULAR) 2017, soutiennent les promesses de 2 nouvelles classes de m&ea...

Searching online from a patient perspective can make you a better doctor

As a pediatric allergist, I treat several conditions that commonly affect children, including asthma, food allergies, eczema and allergic rhinitis. Almost everyone knows someone affected by some form of allergic condition, which makes for frequent questions from families, referring providers, and the public at large. Early in my career, I noticed that many patients (and […]

Skin And Skin Structure Infections SSSIPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Skin And Skin Structure Infections SSSIPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Skin And Skin Structure Infections SSSI. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Re...

LEO Pharma Appoints Chris Posner to Lead US Business

BALLERUP, Denmark, June 23, 2017 /PRNewswire/ -- LEO Pharma today announced that it appointed Chris Posner Executive Vice President Region US and President & CEO, LEO Pharma, Inc. From July 15, 2017, he will be responsible for the US business of LEO Pharma, a global healthcare company dedicated to helping people achieve healthy skin.      (Logo: http://photos.prnews...

New England Area Doctor Welcomes Pelleve Wrinkle Reduction Treatment Into Her Practice

SHREWSBURY, Mass., Jan. 10, 2013 /PRNewswire/ -- Jean Casello, MD, owner and Medical Director of RenovoMD in Shrewsbury, MA, is pleased to announce that her office will now offer the non-invasive skin tightening treatment Pelleve® Wrinkle Reduction System. Dr. Casello is focused on bringing her patients advanced aesthetic services and top-notch care, and that's where Pelleve fits in: ...

Santa Fe-Albuquerque Plastic Surgeon Dr. James Green Now Offers Pelleve Wrinkle Reduction Treatment

ALBUQUERQUE, N.M., Jan. 18, 2013 /PRNewswire/ -- Renowned plastic surgeon James Green, MD, announces that his office will now offer the Pelleve® Wrinkle Reduction System, a new technology for non-invasive skin tightening. Pelleve treats mild to moderate wrinkles, is pain-free and comfortable. Patients report the one-hour treatment feels like a warm massage. The effectivene...

The Skin Cancer Foundation Has Filed a Complaint with the Federal Trade Commission against MTV for Heavily Promoting Tanning in Jersey Shore Program

F.T.C. Urged to Investigate MTV's Promotion of Hazardous and Potentially Deadly Behavior NEW YORK, Jan. 18, 2013 /PRNewswire-USNewswire/ -- The Skin Cancer Foundation yesterday filed a formal complaint with the Federal Trade Commission, asking that the F.T.C. use its authority under Section 5 of the Federal Trade Commission Act to investigate MTV's Jersey Shore television series and rela...

Plastic Surgeon and Consultant Dr. Gregory Buford Shares 5 Ways to Look Younger Without Surgery

DENVER, Jan. 30, 2013 /PRNewswire/ -- A New Year's resolution to reduce the effects of aging doesn't have to involve surgery, says Denver board certified plastic surgeon Dr. Gregory Buford. Aesthetic improvements are possible through a variety of nonsurgical approaches depending on the individual patient's needs. Treatments can improve the surface of the skin, restore lost volume in the face, and...

Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa

SAN DIEGO, February 8, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), today announced the initiation of a Phase 3 study designed to evaluate the efficacy and safety of ABH001, its dermal substitute therapy, for the treatment of non-healing wounds in patients with Epidermolysis Bullosa (EB), a group of rare genetic skin disorders that begin to manifest at birth or early childhood and occ...

Celebrated Photographer Martin Schoeller Shines a Light on People With Psoriatic Disease Including Olympic Swimmer and Author Dara Torres as Part of Celgene’s SHOW MORE OF YOU Campaign

Powerful, New Portraits Aim to Inspire People With Plaque Psoriasis or Psoriatic Arthritis to Show More of Their True Selves Award-winning portrait photographer Martin Schoeller along with 12-time Olympic medalist and New York Times best-selling author Dara Torres and others with psoriatic disease have come together for the SHOW MORE OF YOU campaign fr...

Solta Medical to Present at the Leerink Swann Global Healthcare Conference in New York on February 14, 2013

HAYWARD, Calif., Feb. 4, 2013 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will present at the Leerink Swann Global Healthcare Conference, at the Waldorf Astoria Hotel in New York on Thursday, February 14, 2013 at 11:30 am ET. Stephen J. Fanning, Chairman, President and Chief Executive Officer of Solta Medical, w...

Schweiger Dermatology Group Secures $20M Credit Facility from Triangle Capital Corporation

Schweiger Dermatology Group (“SDG” or the “Company”) announced today that it has secured a $20 million debt facility from Triangle Capital Corporation (NYSE: TCAP) to help fund and support its growth. Under the terms of this facility, the total funding may be increased to $30 million in the near term and has the potential to grow to $50 million ove...

Customers come second: That’s something health care can learn

“Management’s overall aim should be to create a system in which everybody may take joy in his/her work.” – W. Edwards Deming “Your skin is not thick enough to hear me yell for even ten minutes!” a 92-year-old patient’s family member shouted at me while attending a care plan meeting. I was soon asked to […]

BioPharmX to Present Phase 2b Clinical Trial Acne Data at Alabama Dermatology Society Summer Symposium

MENLO PARK, Calif., June 22, 2017 /PRNewswire/-- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company focusing on dermatology, will present results of its phase 2b of BPX-01, a unique topical hydrophilic gel formulation of minocycline, at the Alabama Dermatology Society's Summer Symposium being held June 22-25 in Sandestin, Fla. Findings from the phase 2b will be d...

ECZÉMA : Une manifestation cardiovasculaire ? - British Journal of Dermatology

On connaît le lien entre le psoriasis et un risque cardiovasculaire accru. Cette étude a souhaité vérifier le lien entre eczéma ou dermatite atopique, et les maladies cardiovasculaires. Contrairement à 2 précédentes études, cette très large analyse des dossiers de plus de 250.000 patients atteints de dermatite aboutit à un...

French health system approves reimbursement of QIAGEN's QuantiFERON latent TB test

HILDEN, Germany, and PARIS, June 22, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that France's Ministry of Health and Social Affairs has approved reimbursement by the national health insurance system for QIAGEN's QuantiFERON-TB® Gold Plus (QFT-Plus®) to screen at-risk individuals for latent tuberculosis infection. The French decision to reim...

DURECT Completes Enrollment in PERSIST, Phase 3 trial for POSIMIR®

CUPERTINO, Calif., June 22, 2017 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that patient enrollment has been completed in PERSIST, the pivotal Phase 3 clinical trial of POSIMIR® (SABER®-Bupivacaine), an investigational locally acting, non-opioid analgesic intended to provide up to three days of continuous pain relief after surgery. "The early completion of enrollment ...

Quick Search
Advertisement
 

review and buy Dermatology market research data and corporate reports here